Literature DB >> 9551977

A two-step mechanism for recruitment of Pip by PU.1.

J M Perkel1, M L Atchison.   

Abstract

Transcription of the Ig kappa light chain gene is controlled in part by the 3' kappa enhancer. Two of the proteins that bind to the 3' enhancer, PU.1 and Pip, show tissue-restricted expression and may be responsible for the tissue specificity of 3' enhancer activity. PU.1 alone can bind to DNA; however, Pip cannot bind to its 3' enhancer site in electrophoretic mobility shift assays, unless recruited by PU.1. Previously, we showed that the PU.1 PEST domain (rich in the amino acids proline, glutamate, serine, and threonine; sequences 118-160) is necessary for Pip recruitment to DNA. Here we used detailed mutagenic analyzes of PU.1 to more precisely identify sequences required for Pip recruitment by electrophoretic mobility shift assay. We found that mutation of three segments within the PU.1 PEST domain (118-125, 133-139, and 141-147) modulated the efficiency of Pip recruitment, while mutation of sequences between residues 88-118 and 154-168 had no effect. Interestingly, we found that the PU.1 ETS domain (residues 170 to 255) is both necessary and sufficient for Pip interaction in solution and that other ETS domain proteins can physically interact with Pip as well. Our results suggest that Pip recruitment to DNA by PU.1 occurs via a two-step mechanism. First, a physical interaction that is not sufficient to recruit Pip occurs via the PU.1 ETS domain. Second, a conformational change in the PU.1 PEST domain, apparently mediated by serine phosphorylation, induces a conformational change in Pip enabling it to bind to DNA. We also show that the PU.1 PEST domain does not target PU.1 for rapid turnover.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551977

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.

Authors:  A L Brass; A Q Zhu; H Singh
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

3.  Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Authors:  Jynho Kim; Ricardo A Feldman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

4.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

5.  Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors.

Authors:  B Lubyova; P M Pitha
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Identification of a PU.1-IRF4 protein interaction surface predicted by chemical exchange line broadening.

Authors:  Scott R McKercher; Christian R Lombardo; Andrey Bobkov; Xin Jia; Nuria Assa-Munt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-07       Impact factor: 11.205

7.  PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.

Authors:  Robert Hines; Brenda R Sorensen; Madeline A Shea; Wendy Maury
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain.

Authors:  Soumya G Remesh; Vishaka Santosh; Carlos R Escalante
Journal:  J Biol Chem       Date:  2015-09-24       Impact factor: 5.157

9.  A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.

Authors:  Suchita Hodawadekar; Kyoungsook Park; Michael A Farrar; Michael L Atchison
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

10.  Epigenetic histone modifications do not control Igkappa locus contraction and intranuclear localization in cells with dual B cell-macrophage potential.

Authors:  Suchita Hodawadekar; Fang Wei; Duonan Yu; Andrei Thomas-Tikhonenko; Michael L Atchison
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.